Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryogo Minamimoto

Showing results (61-70 of 148) with videos related to

Pageof 15
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 1, 2017
Prospective Evaluation of <sup>68</sup>Ga-RM2 PET/MRI in Patients with Biochemical Recurrence of Prostate Cancer and Negative Findings on Conventional ImagingRyogo Minamimoto, Ida Sonni, Steven Hancock, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 28, 2015
Pilot prospective evaluation of (18)F-FPPRGD2 PET/CT in patients with cervical and ovarian cancerRyogo Minamimoto, Amer Karam, Mehran Jamali, et al.
Annals of the New York Academy of Sciences|July 2, 2011
FDG PET for rheumatoid arthritis: basic considerations and whole-body PET/CTKazuo Kubota, Kimiteru Ito, Miyako Morooka, et al.
Nuclear Medicine Communications|March 19, 2020
Assessment of tumor response to definitive chemoradiotherapy and prognosis prediction in patients with esophageal cancer judged by PET response criteria in solid tumors: multicenter study in JapanKazuhiro Kitajima, Hayato Kaida, Koya Nakatani, et al.
EJNMMI Research|February 1, 2019
Efficacy of 4'-[methyl-11C] thiothymidine PET/CT before and after neoadjuvant therapy for predicting therapeutic responses in patients with esophageal cancer: a pilot studyMasatoshi Hotta, Ryogo Minamimoto, Kazuhiko Yamada, et al.
Annals of Nuclear Medicine|March 20, 2012
Reevaluation of FDG-PET/CT in patients with hoarseness caused by vocal cord palsyRyogo Minamimoto, Kazuo Kubota, Miyako Morooka, et al.
Nuclear Medicine Communications|October 30, 2015
Evaluation of a new motion correction algorithm in PET/CT: combining the entire acquired PET data to create a single three-dimensional motion-corrected PET/CT imageRyogo Minamimoto, Takuya Mitsumoto, Yoko Miyata, et al.
Modern Rheumatology|November 21, 2013
Clinical value of ¹⁸F-fluoro-dexoxyglucose positron emission tomography/computed tomography in patients with adult-onset Still's disease: a seven-case series and review of the literatureHiroyuki Yamashita, Kazuo Kubota, Yuko Takahashi, et al.
Japanese Journal of Radiology|February 5, 2026
FDG uptake in upper abdominal lymph node as a distinctive pattern in sarcoidosisRyogo Minamimoto, Yumi Abe, Ryota Morimoto, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|March 29, 2018
Significance of <sup>11</sup>C-PIB PET/CT in cardiac amyloidosis compared with <sup>99m</sup>Tc-aprotinin scintigraphy: A pilot studyRyogo Minamimoto, Toru Awaya, Kentaro Iwama, et al.
Pageof 15

Showing results (61-70 of 148) with videos related to

Sort By:
Pageof 15
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 1, 2017
Prospective Evaluation of <sup>68</sup>Ga-RM2 PET/MRI in Patients with Biochemical Recurrence of Prostate Cancer and Negative Findings on Conventional ImagingRyogo Minamimoto, Ida Sonni, Steven Hancock, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 28, 2015
Pilot prospective evaluation of (18)F-FPPRGD2 PET/CT in patients with cervical and ovarian cancerRyogo Minamimoto, Amer Karam, Mehran Jamali, et al.
Annals of the New York Academy of Sciences|July 2, 2011
FDG PET for rheumatoid arthritis: basic considerations and whole-body PET/CTKazuo Kubota, Kimiteru Ito, Miyako Morooka, et al.
Nuclear Medicine Communications|March 19, 2020
Assessment of tumor response to definitive chemoradiotherapy and prognosis prediction in patients with esophageal cancer judged by PET response criteria in solid tumors: multicenter study in JapanKazuhiro Kitajima, Hayato Kaida, Koya Nakatani, et al.
EJNMMI Research|February 1, 2019
Efficacy of 4'-[methyl-11C] thiothymidine PET/CT before and after neoadjuvant therapy for predicting therapeutic responses in patients with esophageal cancer: a pilot studyMasatoshi Hotta, Ryogo Minamimoto, Kazuhiko Yamada, et al.
Annals of Nuclear Medicine|March 20, 2012
Reevaluation of FDG-PET/CT in patients with hoarseness caused by vocal cord palsyRyogo Minamimoto, Kazuo Kubota, Miyako Morooka, et al.
Nuclear Medicine Communications|October 30, 2015
Evaluation of a new motion correction algorithm in PET/CT: combining the entire acquired PET data to create a single three-dimensional motion-corrected PET/CT imageRyogo Minamimoto, Takuya Mitsumoto, Yoko Miyata, et al.
Modern Rheumatology|November 21, 2013
Clinical value of ¹⁸F-fluoro-dexoxyglucose positron emission tomography/computed tomography in patients with adult-onset Still's disease: a seven-case series and review of the literatureHiroyuki Yamashita, Kazuo Kubota, Yuko Takahashi, et al.
Japanese Journal of Radiology|February 5, 2026
FDG uptake in upper abdominal lymph node as a distinctive pattern in sarcoidosisRyogo Minamimoto, Yumi Abe, Ryota Morimoto, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|March 29, 2018
Significance of <sup>11</sup>C-PIB PET/CT in cardiac amyloidosis compared with <sup>99m</sup>Tc-aprotinin scintigraphy: A pilot studyRyogo Minamimoto, Toru Awaya, Kentaro Iwama, et al.
Pageof 15